Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Jonathon’s ICL Experience Shared By Waite Vision
Via Press Advantage
Exposures Product Safety
89bio (NASDAQ: ETNB) Reports Phase 2b ENLIVEN Trial of Pegozafermin Achieved Primary Endpoints For Treatment of Nonalcoholic Steatohepatitis (NASH)
Via Spotlight Growth
Exposures Product Safety
Tickers ETNB
What Is Autologous Cell-Based Therapy, The Treatment Revolutionizing Regenerative Medicine That Could Be Set To Explode Over The Next Few Years?
Via TheNewswire.com
Exposures Product Safety
Tickers BMY GILD JNJ PFE
What Is Autologous Cell-Based Therapy, The Treatment Revolutionizing Regenerative Medicine That Could Be Set To Explode Over The Next Few Years?
Via News Direct
Exposures Product Safety
Tickers BMY GILD JNJ PFE
NICE Rapid Introduces The Best Compression Moulding and Aluminum Extrusion Services For Manufacturing Industries
Via Press Release Distribution Service
Exposures Product Safety
A marathon, not a sprint: Life with chronic myeloid leukemia
Via Brandpoint
Exposures Product Safety
Why did Sarepta Therapeutics Stock Plummet?
Via MarketBeat
Exposures Product Safety
Tickers BMRN FGEN PFE PTC
Kirkman CEO Eric Gripentrog Named CEO of the Year
Via Newsfile
Exposures Product Safety
BioMedNewsBreaks – India Globalization Capital Inc. (NYSE American: IGC) Rebrands, Including Changing Name to IGC Pharma, as Part of ‘Major Milestone’ Alignment
Via Investor Brand Network
Exposures Product Safety
Tickers IGC
Eve Wellness, a SF Breast Ultrasound Screening Clinic supports the recent FDA updates to the guidelines to inform women about breast density
Via PRLog
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
InvestorNewsBreaks – QSAM Biosciences Inc. (QSAM) to Provide Clinical Trial Updates at Emerging Growth Conference
Via Investor Brand Network
Exposures Product Safety
Tickers QSAM
Kadimastem Earns FDA Approval of its IND Application For its US Multi-Site Phase IIa Clinical Trial of AstroRx® to Treat ALS
Via TheNewswire.com
Exposures Product Safety
Kadimastem Earns FDA Approval of its IND Application For its US Multi-Site Phase IIa Clinical Trial of AstroRx® to Treat ALS
Via News Direct
Exposures Product Safety
YMAB FINAL DEADLINE TOMORROW: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Y-mAbs Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important March 20 Deadline in Securities Class Action - YMAB
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers YMAB
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Surmodics Inc. Investors to Inquire About Securities Class Action Investigation - SRDX
Via NewMediaWire
Exposures Product Safety
Tickers SRDX
Houston Entrepreneur Clayton Trier Releases Novel on Mental Health Crisis and Life in Beaumont, TX in the 60s and 70s
Via Get News
Topics Product Recall
Exposures Legal Product Safety
Veggie Chips Market to Eyewitness Massive Growth by 2023-2028 : Four Seasons Fruits, Baboon Bite, Gold Chips
Via SBWire
Exposures Product Safety
Rahim Handy: The Empathetic Storytelling Maverick at Clear Motion Films
Via Get News
Topics Product Recall
Exposures Legal Product Safety
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Releases Q4, FY 2022 Financial Report, Corporate Updates
Via Investor Brand Network
Topics Earnings Intellectual Property
Exposures Financial Intellectual Property Product Safety
Tickers BEAT
InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Doses First Patient in Key Study of Next-Generation Chemotherapy-Capecitabine
Via Investor Brand Network
Exposures Product Safety
Tickers PCSA
NICE Rapid Introduces The Best Compression Moulding and Aluminum Extrusion Services For Manufacturing Industries
Via Newsfile
Exposures Product Safety
ViaDerma Announces FDA Registration Application Update & Brand Name for New Hair Regrowth Product
Via AB Newswire
Exposures Product Safety
Tickers VDRM
Shares Of Inhibikase Therapeutics Stock Decouples From NASDAQ Weakness; Jump 8% Including A/H Wednesday As Interest In Ikt-148009 Intensifies ($IKT)
Via AB Newswire
Exposures Product Safety
Tickers IKT
PsychedelicNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Announces Positive Results from IND-Enabling Toxicology Study of SP-26
Via Investor Brand Network
Exposures Product Safety
Tickers SILO
In The Queue: AcurX Pharmaceuticals Earnings…Here’s What Investors Need To Know Before Thursday ($ACXP)
Via AB Newswire
Exposures Product Safety
Tickers ACXP
Female-Owned Winnipeg Funeral Home Reflects On Five Years In Business As International Women's Day Is Celebrated
Via GetFeatured
Topics Product Recall
Exposures Legal Product Safety
Futura Medical expects FDA approval for topical ED treatment during Q2
Via News Direct
Exposures Product Safety
Tickers FAMDF
Futura Medical expects FDA approval for topical ED treatment during Q2
Via TheNewswire.com
Exposures Product Safety
Tickers FAMDF
Rise in Biotech Innovations Generating Hope as Pancreatic Cancer Survival Rates Climb
Via FinancialNewsMedia
Exposures Product Safety
Tickers AIM AZN BMEA NVS
Inhibikase Therapeutics Stock Turns Bullish After FDA Lifts Full Clinical Hold For Lead Candidate IkT-148009 ($IKT)
Via AB Newswire
Exposures Product Safety
Tickers IKT
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.